The thread shares a video covering an IV muscle-preserving drug for GLP-1 users that is described as unavailable and impractical, then shifts to another agent already being studied with tirzepatide. Participants note the video drifts into unrealistic territory and express doubt that insurance would cover any new expensive option given current GLP-1 coverage refusals. One user simply states a desire for the combination treatment immediately.
What this discussion establishesnull
Still opennull
Nothing here is advice.
The video talks about an intravenous medication meant to preserve muscle while on GLP-1 drugs, but calls it unavailable and unrealistic to use. It then discusses more realistic upcoming options such as another agent already being tested together with tirzepatide, suggesting future obesity treatments might prioritize keeping muscle and function instead of just dropping the highest amount of weight.
I'm dying to get hold of retagrumarolintide right this second!
That connection shown under the starting message keeps functioning.
Doesn't seem all that appealing to me because of the steep cost involved. My plan has already turned down similar treatments so approval for this latest version looks unlikely.
If you have tried it, this topic is still open. Sign in to reply — it takes a minute.